DCM Shriram Industries Limited has announced a postal ballot seeking shareholder approval for four significant board appointments. The company has issued a comprehensive notice under Sections 108 and 110 of the Companies Act, 2013, proposing key changes to its board composition.

E-Voting Timeline and Process

The remote e-voting period for the postal ballot will commence at 9:00 AM IST on Monday, January 26, 2026, and conclude at 5:00 PM IST on Tuesday, February 24, 2026. The company has appointed Mr. Kamaljit Singh (COP No. 16847), a practicing Company Secretary, as the Scrutinizer to conduct the postal ballot process.

Proposed Board Appointments

The postal ballot covers four resolutions for board appointments, each requiring special resolution approval from shareholders.

Independent Directors

The company seeks approval for appointing two Independent Directors for five-year terms from December 10, 2025, to December 9, 2030:

Anurag Surana (DIN: 00006665) brings over 35 years of experience in agrochemical, fine chemical, and specialty chemical industries. He previously served as Executive Director at PI Industries Ltd for 14 years and currently serves as Managing Director & CEO of Kagashin Global Network (P) Ltd. His expertise includes strategic leadership, operations management, and international business development.

Sidharth Prasad (DIN: 00074194), aged 62 years, is a seasoned entrepreneur with decades of experience across sugar, hospitality, real estate, and energy sectors. He serves as a Board Member of L.H. Sugar Factories Limited and as an Independent Director at United Provinces Sugar Company Limited.

Executive Directors

The company also proposes two executive appointments as part of its succession planning:

Uday Shriram (DIN: 11407307), aged 33 years, son of Managing Director Madhav B. Shriram, will be appointed as Deputy Managing Director. He holds degrees from Brown University and brings eight years of experience in analytics leadership and management consulting, including his role as Associate Director at Sanofi Specialty Care.

Rohan Shriram (DIN: 08940521), aged 31 years, also son of the Managing Director, will serve as Whole Time Director. He holds a Bachelor's degree in Economics and Government and has diverse experience across portfolio management, strategy, and business development.

Remuneration Structure

Both executive directors will receive identical compensation packages:

Regulatory Compliance

These appointments align with the company's implementation of a Scheme of Arrangement and board reconstitution requirements. Under Regulation 17(1C) of SEBI (LODR) Regulations, 2015, director appointments must receive shareholder approval within three months.

The company has confirmed that all proposed directors meet independence criteria under Section 149(6) of the Companies Act, 2013, and are not disqualified under Section 164 or debarred by SEBI from holding directorship positions.

Voting Rights and Documentation

Shareholders registered as of the January 19, 2026 cut-off date will be eligible to vote. The company will conduct the process entirely through electronic mode, with notices sent to registered email addresses. Physical postal ballot forms will not be distributed in compliance with MCA circulars.

The postal ballot notice and related documents are available on the company's website, stock exchange portals, and KFin Technologies Limited's e-voting platform. Results will be announced within two working days of the e-voting conclusion and communicated to stock exchanges.

Demerger Implementation Completed

DCM Shriram Industries Limited has successfully completed its composite scheme of arrangement with an effective date of December 17, 2025. The company announced that shares in two new entities have been allotted and credited to eligible shareholders following confirmations received from depositories NSDL and CDSL. The scheme involves the demerger of the company's chemical and rayon business undertakings, previously sanctioned by the National Company Law Tribunal (NCLT) New Delhi Bench on November 21, 2025.

Share Allotment and Corporate Structure Changes

The implementation has resulted in the successful allotment and credit of equity shares to shareholders in both resulting companies. The comprehensive restructuring has fundamentally altered the corporate structure of the group.

Following the allotment, DCM Shriram Fine Chemicals Limited (DSFCL) and DCM Shriram International Limited (DSIL) have ceased to be wholly-owned subsidiaries of DCM Shriram Industries. The cancellation of the entire pre-scheme paid-up share capital of the resulting companies has been completed as per the scheme provisions.

Business Allocation and New Entities

The restructuring has resulted in a clear segregation of business verticals across three entities with distinct operational focus areas.

Listing and Trading Process

Both resulting companies are taking necessary steps to obtain listing and trading permission for the allotted equity shares from BSE Limited and National Stock Exchange of India Limited. The shares will be listed on both exchanges following regulatory approvals.

The company filed the certified copy of the NCLT order with the Registrar of Companies, NCT of Delhi & Haryana in Form INC-28. The boards of directors of all three companies mutually decided to keep December 17, 2025, as the effective date, being the date of filing of Form INC-28 by the resultant companies.

Shareholder Communication and Support

The company has established comprehensive support mechanisms for shareholders during this transition. All relevant information and documents are being communicated through official channels.

For queries and assistance, shareholders can contact:

• Registrar: KFin Technologies Limited at 1800-309-4001 or einward.ris@kfintech.com
• Company: 011-43745075 or investorservices@dcmsr.com

The company will provide guidance on the cost of acquisition for equity shares in all three entities in due course, ensuring shareholders have complete information for their investment decisions.